期刊文献+

肾移植术后的溶血性尿毒综合征 被引量:2

原文传递
导出
摘要 溶血性尿毒综合征(HUS)是移植肾功能障碍的一个少见原因,治疗困难、预后不良。肾移植术后的HUS包括原发HUS的复发和新发HUS两类,后者主要为药物(免疫抑制剂环孢素A和他克莫司、抗血小板药物氯吡格雷等)引起。新发HUS的主要高危因素是感染、急性排斥反应和免疫抑制剂浓度过高。治疗方法主要有:停用诱发药物、调整免疫抑制方案、血浆置换、输注新鲜冰冻血浆和抗凝治疗等。
出处 《国际泌尿系统杂志》 2006年第1期80-83,共4页 International Journal of Urology and Nephrology
  • 相关文献

参考文献27

  • 1Bren A,Pajek J,Grego K,et al.Follow- up of kidney graft recipients with cyclosporine - associated hemolytic - uremic syndrome and thrombotic microangiopathy.Transplant Proc ,2005,37:1889 - 1891.
  • 2Grupp C,Schmidt F,Braun F,et al.Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation-is tacrolimus the answer? Nephrol Dial Transplant,1998,13:1629-1631.
  • 3Franz M,Regele H,Schmaldienst S,et al.Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients:advantage of FK506 therapy? Transplantation,1998,66:1258 - 1262.
  • 4Lin CC,King KL,Chao YW,et al.Tacrolimus - associated hemolytic uremic syndrome:a case analysis.J Nephrol,2003 ,16 :580 - 585.
  • 5Gatti S,Arru M,Reggiani P,et al.Successful treatment of hemolytic uremic syndrome after liver -kidney transplantation.J Nephrol,2003,16:586 - 590.
  • 6Langer RM,Van Buren CT,Katz SM,et al.De noro hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine - sirolimus combination.Transplantation,2002,73:756 - 760.
  • 7Franco A,Hernandez D,Capdevilla L,et al.De novo hemolytic -uremic syndrome/thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors:role of sirolimus.Transplant Proc,2003,35:1764 - 1766.
  • 8Egidi MF,Cowan PA,Naseer A,et al.Conversion to sirolimus in solid organ transplantation:a single - center experience.Transplant Proc,2003,35 :S131 - 137.
  • 9Chiurchiu C,Ruggenenti P,Remuzzi G.Thrombotic microangiopathy in renal transplantation.Ann Transplant ,2002,7:28 - 33.
  • 10Evens AM,Kwann HC,Kaufman DB,et al.TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment:evidence of a nonimmunological etiology.Transplantation,2002,74:885 - 887.

同被引文献31

  • 1<环孢素A在肾内科的应用>专家协作组.环孢素A治疗肾小球疾病的应用共识[J].中华肾脏病杂志,2005,21(9):556-557. 被引量:74
  • 2Goplani KR,Vanikar AV,Shah PR.Postrenal transplant hemolytic uremic syndrome/thrombotic microangiopathy:Ahmedabad experience.Transplant Proc.2008;40(4):1114-1116.
  • 3Zarifian A,Meleg-Smith S,O'donovan R,et al.Cyclosporine-associated thrombotic microangiopathy in renal allografts.Kidney Int.1999; 55 (6):2457-2466.
  • 4Lin CC,King KL,Chao YW,et al.Tacrolimus-associated hemolytic Uremic syndrome:a case analysis.J Nephrol.2003;16(4):580-585.
  • 5Saikali J,Truong L,Suki W.Sirolimus may promote thrombotic microangiopathy.Am J Transplant.2003; 3(2):229-230.
  • 6Sartelet H,Toupance O,Lorenzato M,et al.Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys.Am J Transplant.2005; 5(10):2441-2447.
  • 7Le Quintrac M,Lionet A,Kamar N,et al.Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.Am J Transplant.2008;8(8):1694-1701.
  • 8Cruzado JM,de Córdoba SR,Melilli E,et al.Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor Ⅰ and MCP.Am J Transplant.2009;9(6):1477-1483.
  • 9Chan MR,Thomas CP,Torrealba JR,et al.Recurrent atypical hemolytic uremic syndrome associated with factor Ⅰ mutation in a living related renal transplant recipient.Am J Kidney Dis.2009; 53(2):321-326.
  • 10Davin JC,Strain L,Goodship TH.Plasma therapy in atypical haemolytic uremic syndrome:lessons from a family with a factor H mutation.Pediatr Nephrol.2008;23(9):1517-1521.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部